Infectious Diasease Therapeutics Market Size, Segments, and Trends by 2031
Infectious Disease Therapeutics Market: Strategic Insights
Infectious Disease Therapeutics Market
-
CAGR (2022 - 2030)4.3% -
Market Size 2022
US$ 1,19,708.77 Million -
Market Size 2030
US$ 1,67,883.93 Million
Market Dynamics
GROWTH DRIVERS
- Rising Prevalence of Infectious Disease
- Increasing Focus on Funding and R&D for Infectious Disease Therapeutics
FUTURE TRENDS
- Molecular Diagnostics for Infectious Diseases in Personalized Medicine is the Recent Trend Witnessed in the Market
OPPORTUNITIES
- Growing Opportunities in Developing Nations
Key Players
- Pfizer Inc
- Gilead Sciences Inc
- F Hoffmann La Roche Ltd
- Shionogi Co Ltd
- Bayer AG
- BioCryst Pharmaceuticals Inc
- GSK Plc
- AbbVie Inc
- Merck Co Inc
- Astellas Pharma Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Drug Class - Anti-viral
- Anti Bacterial
- Anti-Fungal
Indication - HIV
- Hepatitis
- Tuberculosis
- Influenza
- HPV
Route of Administration - Oral
- Parenteral
- Topical
Distribution Channel - Hospital Pharmacies
- Retail Pharmacies
Get Free Sample For